Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.29 EUR -0.68%
Market Cap: 18.9m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Balance Sheet

Balance Sheet Decomposition
Biotechnology Assets SA

Current Assets 2.9m
Cash & Short-Term Investments 672.5k
Receivables 2.2m
Non-Current Assets 12.2m
Long-Term Investments 565.2k
PP&E 2.4m
Intangibles 6.5m
Other Non-Current Assets 2.8m
Current Liabilities 3.4m
Accounts Payable 115.7k
Accrued Liabilities 494k
Other Current Liabilities 2.8m
Non-Current Liabilities 4.3m
Long-Term Debt 1.4m
Other Non-Current Liabilities 2.9m

Balance Sheet
Biotechnology Assets SA

Rotate your device to view
Balance Sheet
Currency: EUR
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
1
0
0
1
4
5
1
2
1
0
Cash
0
0
0
0
4
5
1
2
1
0
Cash Equivalents
1
0
0
1
0
0
0
0
0
0
Short-Term Investments
1
1
1
1
1
2
0
0
0
0
Total Receivables
2
2
1
2
9
16
3
3
2
3
Accounts Receivables
2
2
1
1
7
14
3
3
2
3
Other Receivables
0
0
0
0
2
2
0
0
0
0
Inventory
0
0
0
0
7
8
0
0
0
0
Other Current Assets
0
0
0
0
0
0
0
0
0
0
Total Current Assets
4
3
2
3
20
30
3
4
3
4
PP&E Net
3
3
3
3
37
41
3
3
3
2
PP&E Gross
0
0
0
0
0
0
3
3
3
2
Accumulated Depreciation
0
0
0
0
0
0
0
1
2
2
Intangible Assets
5
5
5
5
8
7
6
6
6
5
Goodwill
0
0
3
2
7
7
4
3
3
2
Long-Term Investments
0
0
0
0
2
2
0
0
0
1
Other Long-Term Assets
2
3
3
4
5
5
3
3
3
3
Other Assets
0
0
3
2
7
7
4
3
3
2
Total Assets
15
N/A
15
+1%
16
+8%
18
+10%
79
+352%
93
+17%
20
-78%
20
-2%
18
-7%
17
-10%
Liabilities
Accounts Payable
0
0
0
0
5
3
0
0
0
0
Accrued Liabilities
0
0
0
0
1
1
0
0
0
1
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
1
1
1
0
7
8
1
0
1
1
Other Current Liabilities
1
1
1
2
10
17
8
3
2
2
Total Current Liabilities
2
2
2
2
23
29
10
4
4
4
Long-Term Debt
5
5
5
1
13
11
2
3
3
3
Deferred Income Tax
0
0
0
0
1
1
1
1
1
1
Minority Interest
0
0
0
0
0
0
0
0
0
0
Other Liabilities
0
0
0
6
25
44
4
8
7
3
Total Liabilities
7
N/A
7
+3%
8
+10%
9
+19%
62
+552%
85
+38%
16
-81%
15
-5%
14
-6%
10
-31%
Equity
Common Stock
0
0
0
0
2
2
2
2
3
3
Retained Earnings
3
2
1
1
72
82
91
94
96
94
Additional Paid In Capital
4
4
6
6
86
86
92
95
96
97
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
0
0
0
0
0
0
0
0
Other Equity
1
1
1
1
2
2
1
1
1
1
Total Equity
8
N/A
8
-1%
8
+6%
8
+1%
18
+119%
8
-57%
4
-48%
4
+13%
4
-10%
7
+66%
Total Liabilities & Equity
15
N/A
15
+1%
16
+8%
18
+10%
79
+352%
93
+17%
20
-78%
20
-2%
18
-7%
17
-10%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
39
39
39
46
54
58

See Also

Discover More